About a-team Marketing Services
The knowledge platform for the financial technology industry
The knowledge platform for the financial technology industry

A-Team Insight Blogs

Buy-Side Waking Up To MiFID II Impact On Research Fees, Says Fidessa Executive

Subscribe to our newsletter

In recent weeks, the understanding of how to implement the rules for commission payments set in Europe’s MiFID II regulation has changed, according to David Pearson, head of post-trade strategy at trading platform provider Fidessa.

“The understanding now is that a broker must be paid for services they provide to clients, whatever those services are,” Pearson said. “That also includes research. The buy-side is obligated to make sure it has a process and understands what research it needs — and the value of that research.

“[The regulation] completely changes the landscape of how existing brokers offer their research at a bundled rate, and [buy-side firms] get everything the firm actually issues,” he added. “The process of how research is procured is going to fundamentally change as a result of understanding the inducement which goes hand in hand with this particular space.”

Fidessa has partnered with commission management software provider Commcise to offer the capability to manage payment of fees for research in the manner required under MiFID II once it takes effect in January 2018.

Together, Fidessa and Commcise have taken an algorithmic approach to handling research fee payments, as Amrish Ganatra, managing director and co-founder of Commcise, explained.

“On a trade-by-trade basis, the allocations or accounts that feature part of the trade help determine exactly how much research commission to add on a given trade,” he said. “We make that decision based on looking at the budget for every given allocation within that trade. … We give the buy side the tools to determine what this extra research charge is on a trade-by-trade basis.”

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: GenAI and LLM case studies for Surveillance, Screening and Scanning

As Generative AI (GenAI) and Large Language Models (LLMs) move from pilot to production, compliance, surveillance, and screening functions are seeing tangible results – and new risks. From trade surveillance to adverse media screening to policy and regulatory scanning, GenAI and LLMs promise to tackle complexity and volume at a scale never seen before. But...

BLOG

The US Litigation Paradox: Why Passive Participation is the Key for European Asset Managers

In the second blog of our series on securities litigation claims, we look at how the complexity of fragmented legal jurisdictions globally often deters European asset managers from getting involved in litigation and argue that the simplicity of the US system may mean participation is easier than many European firms are aware of. Access the...

EVENT

AI in Data Management Summit New York City

Following the success of the 15th Data Management Summit NYC, A-Team Group are excited to announce our new event: AI in Data Management Summit NYC!

GUIDE

Corporate Actions 2009 Edition

Rather than detracting attention away from corporate actions automation projects, the financial crisis appears to have accentuated the importance of the vital nature of this data. Financial institutions are more aware than ever before of the impact that inaccurate corporate actions data has on their bottom lines as a result of the increased focus on...